GlassScriptPhysician profile
Subbarao Yarra
NPI 1417928326
$33,688.55
in general payments reported to CMS, 2019-2025
31 companies · $4,182 in 2025
The $4,182 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,814 · 2020: $2,739 · 2021: $2,465 · 2022: $4,320 · 2023: $5,804 · 2024: $10K · 2025: $4,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $8,780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,570.49 |
| Food and Beverage | $8,779.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,511.07 | 2021-2025 | Hawkone, Corevalve Evolut R, Micra |
| Penumbra, INC. | $6,455.74 | 2022-2024 | Indigo System |
| Boston Scientific Corporation | $4,176.16 | 2019-2025 | Watchman Access System, Versacross Access Solution, Patientcare Link |
| Abbott Laboratories | $2,863.67 | 2019-2024 | Dragonfly Opstar, Jeti Peripheral Catheter, Xience Skypoint |
| Abiomed | $1,565.19 | 2019-2025 | Impella |
| Biotronik INC. | $1,175.92 | 2019-2025 | Rivacor 7 Dr-T, Acticor 7 Vr-T Dx, Orsiro Mission |
| Shockwave Medical, INC | $1,068.99 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $1,011.01 | 2019-2025 | Camzyos, Eliquis, Cobenfy |
| Medtronic Vascular, INC. | $884.94 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $742.65 | 2021-2025 | Verquvo, Capvaxive |
| Bard Peripheral Vascular, INC. | $560.84 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $501.82 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $386.82 | 2019-2023 | Farxiga |
| Pfizer INC. | $270.75 | 2019-2024 | |
| Endologix LLC | $237.12 | 2024 | Torus Stent Graft System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $209.57 | 2021-2022 | |
| Inari Medical, INC. | $189.69 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $124.08 | 2019 | |
| Amgen INC. | $123.25 | 2022-2025 | Repatha, Repatha |
| Philips North America LLC | $115.05 | 2023 | |
| Cardiovascular Systems INC. | $107.68 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.81 | 2024 | Lifevest |
| Edwards Lifesciences Corporation | $102.12 | 2021 | |
| Novo Nordisk INC | $59.88 | 2025 | Rybelsus, Ozempic, Wegovy |
| Acist Medical Systems, INC. | $47.20 | 2023 | |
| Bolton Medical INC | $18.45 | 2021-2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Actelion Pharmaceuticals US, INC. | $18.42 | 2019 | |
| Getinge USA Sales, LLC | $17.68 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.99 | 2025 | |
| Tactile Systems Technology INC | $12.79 | 2019 | |
| Angiodynamics, INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subbarao Yarra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.